Genetic variant
rs37369 a variant in the AGXT2 gene
rs37369 is a single-letter difference in the AGXT2 gene, on chromosome 5. It has been reported in connection with Beta-aminoisobutyric acid, urinary excretion of. Carrying it does not, on its own, mean you have or will develop any condition.
What is this?
Your DNA is a long sequence of four letters. At a few million positions, people commonly differ by a single letter; each of those positions is called a SNP (“snip”), and rs37369 is the catalogue number of one of them, in the AGXT2 gene. Which letters you carry there — one copy from each parent — is your genotype.
AGXT2 (alanine--glyoxylate aminotransferase 2): The protein encoded by this gene is a class III pyridoxal-phosphate-dependent mitochondrial aminotransferase. It catalyzes the conversion of glyoxylate to glycine using L-alanine as the amino donor. It is an important regulator of methylarginines and is involved in the control of blood pressure in kidney.
Gene description from NCBI Gene
rs37369''' is a SNP located in the coding region of the alanine-glyoxylate aminotransferase-2 (AG...
From SNPedia
Why might it matter?
ClinVar holds no clinical classification for this variant. That is the usual case: most catalogued variants have no known effect on health.
Conditions it has been reported with
- Beta-aminoisobutyric acid, urinary excretion of
Listed in ClinVar submissions for this variant. Being listed is a report of an association, not a statement that the variant causes the condition in any given person.
Do I have this variant?
If you have taken a consumer DNA test (23andMe, AncestryDNA and similar), you can download its raw data file and check. Create a free account, upload the file, and this page will show the letters you carry at rs37369, if your test read this position.
Connect this with your blood results
A gene is a fixed instruction; a blood test shows what your body is doing now. CheckMyBloods reads the two side by side, so a variant can be set against the markers it could plausibly affect.
Blood markers do not diagnose a genetic condition, and a variant does not explain a blood result on its own. Together, with symptoms and family history, they give a clinician context.
What should I do next?
- Find out whether you carry it. Reading about a variant says nothing about you until you know your genotype.
- Put it in context. Add your blood results, so the variant can be read against what your body is doing.
- Ask questions. Dr. Hemsworth, our AI assistant, can explain this variant and your results in plain English.
- Take anything that worries you to a professional. A GP or genetic counsellor can order a confirmatory test and interpret it with your history.
This page is general information drawn from public research databases. It cannot diagnose anything, and it is not a substitute for advice from a doctor or genetic counsellor who knows your history.
Technical details
- dbSNP ID
- rs37369
- Gene
- AGXT2
- Position (GRCh38)
- chr5:35037009
- Variant type
- snv
- Consequence
- missense variant
- ClinVar classification
- Affects
Genome-wide association studies (20)
| Trait | Risk allele | OR / beta | P-value | Study |
|---|---|---|---|---|
| Urine 3-aminoisobutyrate levels in chronic kidney disease | T | OR 1.98 | 8E-347 | PubMed |
| 3-aminoisobutyrate levels | T | OR 1.04 | 3E-299 | PubMed |
| X-12117 levels | T | OR 0.72 | 3E-286 | PubMed |
| Urinary metabolites | T | OR 1.28 | 7E-262 | PubMed |
| Plasma 3-aminoisobutyrate levels in chronic kidney disease | T | OR 0.81 | 7E-261 | PubMed |
| Urinary metabolites | T | — | 2E-182 | PubMed |
| Urine X-12097 levels in chronic kidney disease | T | OR 0.98 | 4E-123 | PubMed |
| Metabolite levels (3-aminoisobutyrate; __Aminoisobutyrate) | T | OR 0.54 | 3E-122 | PubMed |
| Plasma X-12117 levels in chronic kidney disease | T | OR 0.56 | 7E-120 | PubMed |
| Urinary metabolite modules (eigenmetabolites) in chronic kidney disease | T | β 0.028 | 1E-96 | PubMed |
| X-12117 levels | T | OR 0.58 | 3E-92 | PubMed |
| Urine X-12096 levels in chronic kidney disease | T | OR 0.73 | 5E-87 | PubMed |
| Plasma X-24518 levels in chronic kidney disease | T | OR 0.59 | 9E-84 | PubMed |
| X-24518 levels | T | OR 0.6 | 5E-74 | PubMed |
| X-12117 levels | T | OR 0.67 | 4E-71 | PubMed |
| Serum metabolite levels | C | OR 0.41 | 8E-58 | PubMed |
| Beta-aminoisobutyric acid levels | T | OR 0.39 | 2E-51 | PubMed |
| DMGV levels | T | OR 0.43 | 6E-48 | PubMed |
| Symmetrical dimethylarginine levels | T | OR 0.47 | 1E-40 | PubMed |
| X-24518 levels | T | OR 0.61 | 5E-36 | PubMed |
How common the less frequent letter is
- gnomAD ALL
- 13%
- 1kG AFR
- 36.9%
- 1kG ALL
- 60.6%
- 1kG AMR
- 32.4%
- 1kG EAS
- 42.6%
- 1kG EUR
- 91.4%
- 1kG SAS
- 74.8%
Sources
- dbSNP: rs37369 — the reference record
- ClinVar — clinical interpretations submitted by laboratories
- SNPedia — community-written summaries
- NCBI Gene: AGXT2
- Ensembl: AGXT2
- GWAS Catalog — association studies